We are live on ! Find out more
SMMT icon

Summit Therapeutics
SMMT

97 hedge funds and large institutions have $86.3M invested in Summit Therapeutics in 2023 Q4 according to their latest regulatory filings, with 10 funds opening new positions, 36 increasing their positions, 21 reducing their positions, and 6 closing their positions.

New
Increased
Maintained
Reduced
Closed

787% more call options, than puts

Call options by funds: $896K | Put options by funds: $101K

71% more repeat investments, than reductions

Existing positions increased: 36 | Existing positions reduced: 21

67% more first-time investments, than exits

New positions opened: 10 | Existing positions closed: 6

43% more capital invested

Capital invested by funds: $60.4M → $86.3M (+$25.9M)

4% more funds holding

Funds holding: 93 → 97 (+4)

0.09% more ownership

Funds ownership: 4.63% → 4.72% (+0.09%)

Holders
97
Holders Change
+4
Holders Change %
+4.3%
% of All Funds
1.41%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
10
Increased
36
Reduced
21
Closed
6
Calls
$896K
Puts
$101K
Net Calls
+$795K
Net Calls Change
-$1.14M

Top Buyers

Rank Fund Capital Flow
1
Vanguard Group
Vanguard Group
Pennsylvania
+$1.89M
2
Morgan Stanley
Morgan Stanley
New York
+$1.76M
3
BlackRock
BlackRock
New York
+$1.61M
4
State Street
State Street
Massachusetts
+$390K
5
N
Nuveen
North Carolina
+$362K

Top Sellers

Rank Fund Capital Flow
1
BBA
Baker Bros. Advisors
New York
-$5.87M
2
SAM
Shell Asset Management
Netherlands
-$457K
3
CL
CSS LLC
Illinois
-$286K
4
SPIA
Steward Partners Investment Advisory
New York
-$103K
5
Group One Trading
Group One Trading
Illinois
-$68K
Name Holding Trade Value Shares
Change 		Change in
Stake
Legal & General Group
26
Legal & General Group
United Kingdom
$311K +$1.87K +909 +0.8%
State of Wisconsin Investment Board
27
State of Wisconsin Investment Board
Wisconsin
$301K -$7.77K -3,779 -3%
Jane Street
28
Jane Street
New York
$285K +$225K +109,367 New
CS
29
Credit Suisse
Switzerland
$283K -$6.73K -3,272 -3%
Two Sigma Investments
30
Two Sigma Investments
New York
$277K – – –
SAM
31
Shell Asset Management
Netherlands
$248K -$457K -222,330 -70%
SFI
32
Susquehanna Fundamental Investments
Pennsylvania
$225K – – –
CUAMC
33
China Universal Asset Management Company
China
$212K +$130K +63,168 +353%
AC
34
Aristides Capital
Kentucky
$210K +$166K +80,601 New
American Century Companies
35
American Century Companies
Missouri
$201K +$159K +77,074 New
Janus Henderson Group
36
Janus Henderson Group
United Kingdom
$200K -$220 -107 -0.1%
Manulife (Manufacturers Life Insurance)
37
Manulife (Manufacturers Life Insurance)
Ontario, Canada
$199K +$17.3K +8,411 +12%
ETC
38
Exchange Traded Concepts
Oklahoma
$196K +$39.1K +19,011 +34%
H
39
HoyleCohen
California
$194K – – –
Deutsche Bank
40
Deutsche Bank
Germany
$191K +$16.2K +7,887 +12%
Invesco
41
Invesco
Georgia
$183K -$11.5K -5,570 -7%
ProShare Advisors
42
ProShare Advisors
Maryland
$167K +$6.78K +3,295 +5%
MIM
43
MetLife Investment Management
New Jersey
$165K – – –
UBS AM
44
UBS AM
Illinois
$151K – – –
AIG
45
American International Group
New York
$150K -$479 -233 -0.4%
New York State Common Retirement Fund
46
New York State Common Retirement Fund
New York
$126K -$442 -215 -0.4%
Mercer Global Advisors
47
Mercer Global Advisors
Colorado
$126K – – –
VOYA Investment Management
48
VOYA Investment Management
Georgia
$125K +$3.56K +1,729 +4%
Zurich Cantonal Bank
49
Zurich Cantonal Bank
Switzerland
$104K +$29K +14,098 +55%
VW
50
Vance Wealth
California
$102K – – –
1
2
3 4 5

SMMT Hedge Fund Activity: Q4 2023 in Review

97 of the 6,859 institutional investors tracked by Wall St. Rank reported a position in Summit Therapeutics (SMMT) for Q4 2023, worth a combined $86.3M — up 43% from $60.4M a quarter earlier.

Buyers outnumbered sellers: 10 funds opened new SMMT positions and 6 closed out — a net gain of 4 holders — while 36 added to existing stakes and 21 trimmed.

The largest buyer was Vanguard Group, adding an estimated $1.89M. The largest seller was Baker Bros. Advisors, exiting entirely with an estimated $5.87M sold.

  • 97 institutional investors held Summit Therapeutics (SMMT) as of Q4 2023, up from 93 in Q3 2023.
  • Funds reported $86.3M of Summit Therapeutics stock for Q4 2023, up 43% quarter-over-quarter.
  • 10 funds opened new Summit Therapeutics positions in Q4 2023 and 6 closed out, a net change of +4 holders.
  • The largest Summit Therapeutics buyer in Q4 2023 was Vanguard Group, an estimated $1.89M added.
  • The largest Summit Therapeutics seller in Q4 2023 was Baker Bros. Advisors, an estimated $5.87M sold.

Based on aggregated 13F filings for Q4 2023.